Michael Schuster
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Mesenchymal stem cell research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Protein Degradation and Inhibitors 6
- Genomics and Phylogenetic Studies 3
- Hematology 23
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 7
- Co-authors
- Christoph Bock (21 shared papers)Konstantin H. Dragnev (1 shared paper)Jeff Smith (1 shared paper)James R. Rigas (1 shared paper)Karl Kuchler (4 shared papers)Paul G. Richardson (3 shared papers)Kent Holland (1 shared paper)Joseph P. McGuirk (2 shared papers)
- Journals
- Blood (10 papers)Psychosomatics (3 papers)Cell Reports (3 papers)Journal of Clinical Oncology (3 papers)Leukemia (2 papers)
- Partner nations
- United StatesAustriaGermany
In The Last Decade
Michael Schuster
72 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 128
- Hematology 871
- Genetics 657
- Oncology 676
- Molecular Biology 1.6k
- Cancer Research 223
Countries citing papers authored by Michael Schuster
This map shows the geographic impact of Michael Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schuster more than expected).
Fields of papers citing papers by Michael Schuster
This network shows the impact of papers produced by Michael Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schuster. The network helps show where Michael Schuster may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Schuster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 480 | |
| 2 | 2009 | 332 | |
| 3 | 2011 | 203 | |
| 4 | 2019 | 201 | |
| 5 | 2015 | 196 | |
| 6 | 2015 | 140 | |
| 7 | 2003 | 128 | |
| 8 | 2016 | 113 | |
| 9 | 2021 | 100 | |
| 10 | 2015 | 73 | |
| 11 | 1996 | 56 | |
| 12 | 2004 | 45 | |
| 13 | Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series. | 2008 | 43 |
| 14 | 2002 | 42 | |
| 15 | 2010 | 41 | |
| 16 | 2016 | 38 | |
| 17 | 2014 | 37 | |
| 18 | 2017 | 36 | |
| 19 | 2006 | 34 | |
| 20 | 1992 | 33 |
About Michael Schuster
Michael Schuster is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Public Health, Environmental and Occupational Health, having authored 76 papers that have together received 3.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Protein Degradation and Inhibitors (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Genomics and Phylogenetic Studies (3 papers). The work is most often cited by research in Hematology (871 citations), Genetics (657 citations), Oncology (676 citations), Molecular Biology (1.6k citations) and Cancer Research (223 citations). Michael Schuster has collaborated with scholars based in United States, Austria and Germany. Frequent co-authors include Christoph Bock, Konstantin H. Dragnev, Jeff Smith, James R. Rigas, Karl Kuchler, Paul G. Richardson, Kent Holland, Joseph P. McGuirk, Partow Kebriaei and Rod Monroy. Their work appears in journals such as Blood, Psychosomatics, Cell Reports, Journal of Clinical Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.